Nifty Pharma Today Rises 1.02% to Lead Sector Gains

Updated: 11 Aug 2026 • 4:16 pm

Posted by:

Nifty Pharma Today Rises 1.02% to Lead Sector Gains

Quick sector takeaways

Nifty Pharma ended 270.90 points, or 1.02%, higher at 26,750.45 on 11 August 2026, compared with its previous close of 26,479.55.
The index was the top gaining sector index among the configured sector indices, with 11 of 20 tracked stocks advancing and nine declining.
Gland Pharma, Zydus Lifesciences, Dr. Reddy’s Laboratories, Ipca Laboratories and Divi’s Laboratories were prominent gainers, while JB Chemicals & Pharmaceuticals led the decliners.
For the next session, market participants can track whether strength in the leading gainers remains broad-based and how the index behaves around its session high of 26,757.90.

Nifty Pharma today: closing bell wrap

The nifty pharma today closing update shows a firm end to the session. The index finished at 26,750.45, up 270.90 points from the previous close of 26,479.55. Its 1.02% advance placed pharma at the top of the configured sector-index gainers for the day.

The session’s movement was positive from the open of 26,506.00, though the index also traded below the prior close at its day low of 26,422.55. It subsequently moved higher and closed only 7.45 points below the day high of 26,757.90. That closing position is an observation of where the index settled within its intraday range, rather than a forecast for the next session.

The closing picture also reflected selective participation rather than a uniform move across every pharma name. The gainers included several sharp advances, while a meaningful group of stocks ended lower. Readers can follow the wider market context through Univest Market View.

Price snapshot

Nifty Pharma opened at 26,506.00 and traded in a 335.35-point range between 26,422.55 and 26,757.90. The final level of 26,750.45 was above both the opening level and previous close. Against the prior close, the index added 270.90 points, equivalent to 1.02%.

Measure	Level	Session reading
Previous close	26,479.55	Reference level for the day
Open	26,506.00	Started above the previous close
Day low	26,422.55	Lowest intraday level
Day high	26,757.90	Highest intraday level
Close/LTP	26,750.45	Up 270.90 points or 1.02%

Sector ranking

Pharma was the strongest configured sector index in this closing snapshot. Its 1.02% rise exceeded the gains recorded by Nifty IT, which rose 0.61%, and Nifty Mid Select, which gained 0.20%. This ranking is based on the reported percentage movement of the configured sector indices for the session.

The distinction matters because Nifty Pharma’s advance occurred while several other tracked sector indices finished lower. The index therefore stood out on relative sector performance, even as stock-level outcomes within pharma remained mixed. The ranking describes the day’s completed move; it does not establish a reason for it or a directional view beyond the session.

Constituent breadth

Breadth was positive, with 11 advancing stocks and nine declining stocks among 20 display-safe pharma stocks. The advance-decline ratio was 1.22. There were no unchanged stocks. This gives the index gain a broader base than a move driven by only one or two stocks, while the nine decliners show that participation was not one-sided.

The contrast between the index’s 1.02% rise and the mixed breadth is useful for interpreting the close. Large gains in selected names coincided with smaller advances in others and declines elsewhere. As a result, the sector finished strong at the index level without every constituent moving in the same direction.

Heavyweights versus broader participation

Among the supplied heavyweight names, Divi’s Laboratories rose 3.36% to 8,578.50 and ended at its day high. Dr. Reddy’s Laboratories gained 3.99% to 1,205.00, closing close to its intraday high of 1,206.60. These moves sat alongside a 0.12% decline in Sun Pharmaceutical Industries, a 0.32% fall in Cipla and a 0.77% decline in Torrent Pharmaceuticals.

The supplied most-active list contains Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla and Dr. Reddy’s Laboratories. Their mixed closing changes reinforce the point that the sector’s leadership came with differentiated stock performance. Divi’s Laboratories and Dr. Reddy’s were positive contributors within this group, while the other named stocks closed marginally lower.

Key Nifty Pharma stocks

Stock	Move	Why it matters
Gland Pharma	+9.64% to 2,924.40	Largest percentage gainer among the supplied names.
Zydus Lifesciences	+6.43% to 1,191.00	One of the strongest advances in the sector.
Dr. Reddy’s Laboratories	+3.99% to 1,205.00	A heavyweight stock that finished near its day high.
Divi’s Laboratories	+3.36% to 8,578.50	Closed at its intraday high.
JB Chemicals & Pharmaceuticals	-3.87% to 2,408.90	Largest percentage decliner among the supplied names.

Biggest positive movers

Gland Pharma led the gainers with a 9.64% rise to 2,924.40 after trading between 2,808.00 and 2,988.40. Zydus Lifesciences climbed 6.43% to 1,191.00, with a day high of 1,205.00. Dr. Reddy’s Laboratories advanced 3.99%, Ipca Laboratories gained 3.71% to 1,748.40, and Divi’s Laboratories added 3.36%.

These are the day’s reported price moves. Their prominence helps explain the favourable sector-level outcome, but the available price data alone does not assign causes to the advances.

Biggest negative movers

JB Chemicals & Pharmaceuticals fell 3.87% to 2,408.90 after touching an intraday high of 2,525.50 and low of 2,380.00. Alkem Laboratories declined 1.27% to 5,527.50. Lupin was down 0.92%, Torrent Pharmaceuticals lost 0.77%, and Mankind Pharma slipped 0.53%.

These declines are important in the breadth reading because they demonstrate that the sector rally had countervailing stock-specific moves. The closing index gain therefore represented net strength across the basket rather than universal advances.

Stocks to watch next session

Gland Pharma: after a 9.64% rise, its next-session range can be tracked against today’s 2,808.00-2,988.40 band.
Zydus Lifesciences: it closed at 1,191.00 following a 6.43% gain and reached 1,205.00 intraday.
Dr. Reddy’s Laboratories: the stock ended at 1,205.00 after a 3.99% advance.
Divi’s Laboratories: it finished at its day high of 8,578.50 after gaining 3.36%.
JB Chemicals & Pharmaceuticals: it closed at 2,408.90, down 3.87%, making its next move relevant to the sector’s breadth.
Ipca Laboratories: it gained 3.71% to 1,748.40 and reached 1,751.90 during the day.

The constructive case

The constructive evidence from the session is clear: Nifty Pharma led the configured sector indices with a 1.02% gain, closed above its previous close and opening level, and settled near its day high. Positive breadth of 11 advances against nine declines added support to the index-level move.

Sharp advances in Gland Pharma and Zydus Lifesciences, alongside gains in Dr. Reddy’s Laboratories, Ipca Laboratories and Divi’s Laboratories, provided visible positive participation. The latter two heavyweight names, Dr. Reddy’s and Divi’s, also ended close to or at their intraday highs.

The cautious case

The positive close should be read alongside the nine decliners in the 20-stock group. JB Chemicals & Pharmaceuticals fell 3.87%, while Alkem Laboratories, Lupin, Torrent Pharmaceuticals, Mankind Pharma, Cipla, Sun Pharmaceutical Industries, Natco Pharma and Biocon also ended lower.

In addition, Nifty Pharma did trade down to 26,422.55 during the session before recovering. The day’s range and mixed stock outcomes underline why follow-through in the next session remains a key observation point.

Univest Insights

The nifty pharma today performance was notable for both its relative sector leadership and its close near the session high. At 26,750.45, the index retained most of its intraday advance after moving up from its 26,506.00 opening level.

The breadth measure adds useful context. With 11 gainers and nine losers, the sector had a positive but measured participation profile. This is different from a uniformly rising basket, and it places attention on whether advancing names can remain influential in the next session.

Gland Pharma and Zydus Lifesciences delivered the largest percentage gains among the supplied stocks, while Divi’s Laboratories and Dr. Reddy’s Laboratories added strength among the listed heavyweight names. At the same time, weakness in JB Chemicals & Pharmaceuticals and several other stocks kept the closing picture mixed beneath the index headline.

For traders and investors, the key signal to watch is…

Published on 11 August 2026 at 4:15 PM IST

Frequently asked questions

What was Nifty Pharma today?

Nifty Pharma closed at 26,750.45 on 11 August 2026, up 270.90 points or 1.02% from 26,479.55.

Why was Nifty Pharma the top gaining sector index?

Its 1.02% rise was the highest gain among the configured sector indices in the supplied closing data.

What were Nifty Pharma’s day high and day low?

The index recorded a day high of 26,757.90 and a day low of 26,422.55.

How was the breadth in Nifty Pharma?

Eleven stocks advanced and nine declined among 20 display-safe stocks, with no unchanged stocks.

Which stocks led Nifty Pharma gainers?

Gland Pharma, Zydus Lifesciences, Dr. Reddy’s Laboratories, Ipca Laboratories and Divi’s Laboratories were the leading gainers in the supplied data.

Which stock was the biggest Nifty Pharma decliner?

JB Chemicals & Pharmaceuticals was the biggest percentage decliner, falling 3.87% to 2,408.90.

Data as of 11 August 2026 at 4:15:00 PM IST.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.